glycine has been researched along with Alloxan Diabetes in 64 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this paper was to investigate the effect of the oral administration of L-glycine (Gly) on the development of diabetic cataract induced by streptozotocin (STZ) in rats." | 7.78 | Glycine therapy inhibits the progression of cataract in streptozotocin-induced diabetic rats. ( Aldavood, SJ; Bahmani, F; Bathaie, SZ; Ghahghaei, A, 2012) |
| "Mice with thermal and mechanical hypersensitivity after partial ligation of the sciatic nerve (Seltzer model) or mice with mechanical hypersensitivity after streptozotocin injection received intrathecal injection of glycine, sarcosine, and N-[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine." | 7.74 | Glycine transporter inhibitors as a potential therapeutic strategy for chronic pain with memory impairment. ( Kodama, D; Ono, H; Takasu, K; Tanabe, M; Yamaguchi, S, 2008) |
| "Glycine treatment increased body weight gain, reduced blood glucose, and increased plasma insulin levels compared to diabetic control rats, and also increased GSH content and decreased mRNA and protein levels of aldose reductase compared to their respective controls." | 5.51 | Protective effect of glycine in streptozotocin-induced diabetic cataract through aldose reductase inhibitory activity. ( Li, W; Shao, N; Zhang, Y, 2019) |
| "Hydrogen sulfide (H2S) is a gasotransmitter endogenously generated from the metabolism of L-cysteine by action of two main enzymes called cystathionine β-synthase (CBS) and cystathionine γ-lyase (CSE)." | 5.39 | Role of hydrogen sulfide in the pain processing of non-diabetic and diabetic rats. ( Araiza-Saldaña, CI; Barragán-Iglesias, P; Flores-Murrieta, FJ; Godínez-Chaparro, B; Navarrete, A; Roa-Coria, JE; Rocha-González, HI; Torres-López, JE; Velasco-Xolalpa, ME, 2013) |
| "The purpose of this paper was to investigate the effect of the oral administration of L-glycine (Gly) on the development of diabetic cataract induced by streptozotocin (STZ) in rats." | 3.78 | Glycine therapy inhibits the progression of cataract in streptozotocin-induced diabetic rats. ( Aldavood, SJ; Bahmani, F; Bathaie, SZ; Ghahghaei, A, 2012) |
| "Mice with thermal and mechanical hypersensitivity after partial ligation of the sciatic nerve (Seltzer model) or mice with mechanical hypersensitivity after streptozotocin injection received intrathecal injection of glycine, sarcosine, and N-[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine." | 3.74 | Glycine transporter inhibitors as a potential therapeutic strategy for chronic pain with memory impairment. ( Kodama, D; Ono, H; Takasu, K; Tanabe, M; Yamaguchi, S, 2008) |
| " In order to elucidate the significance of GAA synthesis in the pancreas, the author measured serum concentration of GAA, creatine, and the renal and pancreatic GAT activity in control, streptozotocin (STZ)-induced diabetic, insulin-treated diabetic, and ethionine-induced acute pancreatitis rats." | 3.67 | [Study of impaired metabolism of guanidinoacetic acid in uremia--the compensatory role of the pancreas in guanidinoacetic acid synthesis]. ( Hirata, M, 1989) |
| "Glycine treatment increased body weight gain, reduced blood glucose, and increased plasma insulin levels compared to diabetic control rats, and also increased GSH content and decreased mRNA and protein levels of aldose reductase compared to their respective controls." | 1.51 | Protective effect of glycine in streptozotocin-induced diabetic cataract through aldose reductase inhibitory activity. ( Li, W; Shao, N; Zhang, Y, 2019) |
| "Diabetic neuropathic pain (DNP) is a common clinical problem, and the mechanisms underlying the onset and progression of this complication are poorly understood." | 1.43 | Reduction of spinal glycine receptor-mediated miniature inhibitory postsynaptic currents in streptozotocin-induced diabetic neuropathic pain. ( Chiu, YC; Liao, WT; Lin, CR; Liu, CK; Wu, CH, 2016) |
| " Moreover, chronic administration of JTT-551 showed an antiobesity effect and an improvement of glucose and lipid metabolism in DIO mice." | 1.40 | Pharmacological effects of JTT-551, a novel protein tyrosine phosphatase 1B inhibitor, in diet-induced obesity mice. ( Fukuda, S; Ito, M; Morinaga, H; Ohta, T; Sakata, S, 2014) |
| "Choline treatment did not attenuate hyperglycaemic development." | 1.39 | Choline treatment affects the liver reticuloendothelial system and plasma fatty acid composition in diabetic rats. ( Al-Saeedi, FJ; Cheng, B, 2013) |
| "Hydrogen sulfide (H2S) is a gasotransmitter endogenously generated from the metabolism of L-cysteine by action of two main enzymes called cystathionine β-synthase (CBS) and cystathionine γ-lyase (CSE)." | 1.39 | Role of hydrogen sulfide in the pain processing of non-diabetic and diabetic rats. ( Araiza-Saldaña, CI; Barragán-Iglesias, P; Flores-Murrieta, FJ; Godínez-Chaparro, B; Navarrete, A; Roa-Coria, JE; Rocha-González, HI; Torres-López, JE; Velasco-Xolalpa, ME, 2013) |
| "Hydrogen sulfide (H(2)S) displays anti-inflammatory and cytoprotective activities to attenuate myocardial ischemia-reperfusion (MIR)-induced injury, but its role in MIR in diabetics is not known." | 1.37 | The protective role of hydrogen sulfide in myocardial ischemia-reperfusion-induced injury in diabetic rats. ( Gao, Y; Kang, K; Li, W; Sun, L; Sun, X; Yao, X; Zhang, Y, 2011) |
| "The muraglitazar-treated mice had normal plasma glucose, and insulin levels, equivalent or higher pancreatic insulin content than normal mice, showed a robust insulin response to glucose and exhibited greater glucose tolerance." | 1.34 | The dual peroxisome proliferator-activated receptor alpha/gamma activator muraglitazar prevents the natural progression of diabetes in db/db mice. ( Belder, R; Chen, S; Cheng, PT; Devasthale, P; Egan, D; Farrelly, D; French, M; Gu, L; Hariharan, N; Harrity, T; Janovitz, E; Kunselman, L; Peters, A; Ponticiello, R; Staal, A; Swartz, J; Taylor, S; Tozzo, E; Welzel, G; Whaley, J; Zebo, R, 2007) |
| "Glycine-treated diabetic rats showed an important diminution in the percentage of animals with opacity in lens and microaneurysms in the eyes." | 1.33 | Oral glycine administration attenuates diabetic complications in streptozotocin-induced diabetic rats. ( Alvarado-Vásquez, N; Carvajal-Sandoval, G; Cerón, E; Guevara, J; Lascurain, R; Montaño, LF; Tapia, A; Vanda, B; Zenteno, E, 2006) |
| "Proteinuria is the clinical hallmark of diabetic nephropathy and the harbinger of progressive renal disease." | 1.27 | Phosphate restriction reduces proteinuria of the uninephrectomized, diabetic rat. ( Conger, JD; Falk, SA; Hammond, WS; Harris, DC; Schrier, RW, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (34.38) | 18.7374 |
| 1990's | 9 (14.06) | 18.2507 |
| 2000's | 9 (14.06) | 29.6817 |
| 2010's | 18 (28.13) | 24.3611 |
| 2020's | 6 (9.38) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, Y | 1 |
| Lu, Y | 1 |
| Wu, C | 1 |
| Chen, J | 2 |
| Ning, N | 1 |
| Yang, Z | 1 |
| Guo, Y | 1 |
| Zhang, J | 4 |
| Hu, X | 1 |
| Wang, Y | 2 |
| Wang, KX | 1 |
| Liang, FX | 1 |
| Wu, S | 1 |
| Chen, S | 2 |
| Luo, ZH | 1 |
| Han, YL | 1 |
| Chen, B | 1 |
| Chen, ZQ | 1 |
| Zhang, YL | 1 |
| Zhou, T | 1 |
| Gu, XL | 1 |
| Handzlik, MK | 1 |
| Gengatharan, JM | 1 |
| Frizzi, KE | 1 |
| McGregor, GH | 1 |
| Martino, C | 1 |
| Rahman, G | 1 |
| Gonzalez, A | 1 |
| Moreno, AM | 1 |
| Green, CR | 1 |
| Guernsey, LS | 1 |
| Lin, T | 1 |
| Tseng, P | 1 |
| Ideguchi, Y | 1 |
| Fallon, RJ | 1 |
| Chaix, A | 1 |
| Panda, S | 1 |
| Mali, P | 1 |
| Wallace, M | 1 |
| Knight, R | 1 |
| Gantner, ML | 1 |
| Calcutt, NA | 1 |
| Metallo, CM | 1 |
| Mesgari-Abbasi, M | 1 |
| Valizadeh, H | 1 |
| Mirzakhani, N | 1 |
| Vahdatpour, T | 1 |
| Jog, R | 1 |
| Chen, G | 1 |
| Wang, J | 1 |
| Leff, T | 1 |
| Chen, L | 3 |
| Li, C | 1 |
| Wang, Z | 3 |
| Li, J | 3 |
| Zhao, D | 3 |
| Wang, S | 2 |
| Zhang, H | 3 |
| Huang, Y | 1 |
| Guo, X | 3 |
| Wang, L | 1 |
| Li, W | 3 |
| Zhu, Y | 1 |
| Jia, Y | 1 |
| Xu, J | 1 |
| Chai, Y | 1 |
| Yuan, G | 1 |
| Yang, G | 1 |
| Król, E | 1 |
| Krejpcio, Z | 1 |
| Okulicz, M | 1 |
| Śmigielska, H | 1 |
| Zhang, Y | 2 |
| Shao, N | 1 |
| Al-Saeedi, FJ | 1 |
| Cheng, B | 1 |
| Velasco-Xolalpa, ME | 1 |
| Barragán-Iglesias, P | 1 |
| Roa-Coria, JE | 1 |
| Godínez-Chaparro, B | 1 |
| Flores-Murrieta, FJ | 1 |
| Torres-López, JE | 1 |
| Araiza-Saldaña, CI | 1 |
| Navarrete, A | 1 |
| Rocha-González, HI | 1 |
| Wang, CH | 1 |
| Wang, SS | 1 |
| Ko, WJ | 1 |
| Chen, YS | 1 |
| Chang, CY | 1 |
| Chang, RW | 1 |
| Chang, KC | 1 |
| Ito, M | 1 |
| Fukuda, S | 1 |
| Sakata, S | 1 |
| Morinaga, H | 1 |
| Ohta, T | 1 |
| Kuchler, U | 1 |
| Keibl, C | 1 |
| Fügl, A | 1 |
| Schwarze, UY | 1 |
| Tangl, S | 1 |
| Agis, H | 1 |
| Gruber, R | 1 |
| Stec, DF | 1 |
| Stothers, C | 1 |
| Avance, J | 1 |
| Denson, D | 1 |
| Harris, R | 1 |
| Voziyan, P | 1 |
| Nguyen, HT | 1 |
| Bhattarai, JP | 1 |
| Park, SJ | 1 |
| Lee, JC | 1 |
| Cho, DH | 1 |
| Han, SK | 1 |
| Chiu, YC | 1 |
| Liao, WT | 1 |
| Liu, CK | 1 |
| Wu, CH | 1 |
| Lin, CR | 1 |
| El-Sayed, SS | 1 |
| Zakaria, MN | 1 |
| Abdel-Ghany, RH | 1 |
| Abdel-Rahman, AA | 1 |
| Sharma, R | 1 |
| Kaur, J | 1 |
| Mahmood, A | 2 |
| Saigusa, D | 1 |
| Suzuki, N | 1 |
| Takahashi, M | 1 |
| Shiba, K | 1 |
| Tanaka, S | 1 |
| Abe, T | 1 |
| Hishinuma, T | 1 |
| Tomioka, Y | 1 |
| Al-Saeedi, F | 1 |
| Loutfi, I | 1 |
| Gao, Y | 1 |
| Yao, X | 1 |
| Kang, K | 1 |
| Sun, L | 1 |
| Sun, X | 1 |
| Bahmani, F | 1 |
| Bathaie, SZ | 1 |
| Aldavood, SJ | 1 |
| Ghahghaei, A | 1 |
| Alvarado-Vásquez, N | 2 |
| Zamudio, P | 1 |
| Cerón, E | 2 |
| Vanda, B | 2 |
| Zenteno, E | 2 |
| Carvajal-Sandoval, G | 2 |
| KRAHL, ME | 1 |
| BARNABEI, O | 1 |
| MORSIANI, M | 1 |
| FERRARI, R | 1 |
| SAID, A | 1 |
| EL-HAWARY, MF | 1 |
| BENTOR, V | 1 |
| WERTHEIMER, HE | 1 |
| BEGIN, N | 1 |
| SCHOLEFIELD, PG | 1 |
| EICHHORN, JH | 1 |
| SNIFFEN, RC | 1 |
| Liu, CT | 1 |
| Chen, KM | 1 |
| Lee, SH | 1 |
| Tsai, LJ | 1 |
| Lascurain, R | 1 |
| Tapia, A | 1 |
| Guevara, J | 1 |
| Montaño, LF | 1 |
| Tozzo, E | 1 |
| Ponticiello, R | 1 |
| Swartz, J | 1 |
| Farrelly, D | 1 |
| Zebo, R | 1 |
| Welzel, G | 1 |
| Egan, D | 1 |
| Kunselman, L | 1 |
| Peters, A | 1 |
| Gu, L | 1 |
| French, M | 1 |
| Devasthale, P | 1 |
| Janovitz, E | 1 |
| Staal, A | 1 |
| Harrity, T | 1 |
| Belder, R | 1 |
| Cheng, PT | 1 |
| Whaley, J | 1 |
| Taylor, S | 1 |
| Hariharan, N | 1 |
| Tanabe, M | 1 |
| Takasu, K | 1 |
| Yamaguchi, S | 1 |
| Kodama, D | 1 |
| Ono, H | 1 |
| Funahashi, M | 1 |
| Kato, H | 1 |
| Shiosaka, S | 1 |
| Nakagawa, H | 1 |
| Hasslacher, C | 1 |
| Kopischke, HG | 1 |
| Bürklin, E | 1 |
| Gechter, F | 1 |
| Reichenbacher, R | 1 |
| Kiyatake, I | 1 |
| Nandhini, D | 1 |
| Maneemegalai, S | 1 |
| Elangovan, V | 1 |
| Sekar, N | 1 |
| Govindasamy, S | 1 |
| Vilchis, C | 1 |
| Salceda, R | 1 |
| Field, MJ | 1 |
| McCleary, S | 1 |
| Boden, P | 1 |
| Suman-Chauhan, N | 1 |
| Hughes, J | 1 |
| Singh, L | 1 |
| Slomowitz, LA | 2 |
| Peterson, OW | 1 |
| Thomson, SC | 2 |
| Carvajal Sandoval, G | 1 |
| Juárez, E | 1 |
| Ramos Martínez, G | 1 |
| Carvajal Juárez, ME | 1 |
| Medina-Santillán, R | 1 |
| Seino, K | 1 |
| Tun, T | 1 |
| Ohshima, N | 1 |
| Hamada, H | 1 |
| Yoshino, K | 1 |
| Ikeda, S | 1 |
| Fukunaga, K | 1 |
| Taniguchi, H | 1 |
| Takada, Y | 1 |
| Yuzawa, K | 1 |
| Otsuka, M | 1 |
| Todoroki, T | 1 |
| Fukao, K | 1 |
| Deng, A | 1 |
| Hammes, JS | 1 |
| Gabbai, F | 1 |
| Aukunuru, JV | 1 |
| Sunkara, G | 1 |
| Ayalasomayajula, SP | 1 |
| DeRuiter, J | 1 |
| Clark, RC | 1 |
| Kompella, UB | 1 |
| Schedl, HP | 2 |
| Wenger, J | 1 |
| Adibi, SA | 1 |
| De Nicola, L | 1 |
| Blantz, RC | 1 |
| Gabbai, FB | 1 |
| Siow, Y | 1 |
| Schurr, A | 1 |
| Vitale, GC | 1 |
| Wrobel, J | 1 |
| Millen, J | 1 |
| Sredy, J | 1 |
| Dietrich, A | 1 |
| Gorham, BJ | 1 |
| Malamas, M | 1 |
| Kelly, JM | 1 |
| Bauman, JG | 1 |
| Harrison, MC | 1 |
| Jones, LR | 1 |
| Hirata, M | 1 |
| Hetenyi, G | 1 |
| Anderson, PJ | 1 |
| Raman, M | 1 |
| Ferrarotto, C | 1 |
| Harris, DC | 1 |
| Falk, SA | 1 |
| Conger, JD | 1 |
| Hammond, WS | 1 |
| Schrier, RW | 1 |
| Nissim, I | 1 |
| Lapidot, A | 1 |
| Lal, D | 1 |
| Varma, SD | 1 |
| Balegno, HF | 1 |
| Neuhaus, OW | 1 |
| Sadahiro, R | 1 |
| Takeuchi, N | 1 |
| Kumagai, A | 1 |
| Yamamura, Y | 1 |
| Yesair, DW | 1 |
| Mita, I | 1 |
| Nakajima, T | 1 |
| Toshioka, N | 1 |
| Chiba, T | 4 |
64 other studies available for glycine and Alloxan Diabetes
| Article | Year |
|---|---|
Conductive dual hydrogen bonding hydrogels for the electrical stimulation of infected chronic wounds.
Topics: Aniline Compounds; Animals; Biofilms; Cell Survival; Chitosan; Compressive Strength; Diabetes Mellit | 2021 |
[Electroacupuncture preconditioning alleviates renal injury and oxidative stress through Sirt3/MnSOD pathway in type 2 diabetic rats].
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acupuncture Points; Animals; Catalase; Diabetes Mellitus, Experimental; | 2022 |
Insulin-regulated serine and lipid metabolism drive peripheral neuropathy.
Topics: Adiposity; Animals; Diabetes Mellitus, Experimental; Diet, High-Fat; Dyslipidemias; Glycine; Insulin | 2023 |
Protective effects of di- and tri-peptides containing proline, glycine, and leucine on liver enzymology and histopathology of diabetic mice.
Topics: Amino Acid Sequence; Animals; Diabetes Mellitus, Experimental; Glycine; Leucine; Liver; Mice; Peptid | 2022 |
Hormonal regulation of glycine decarboxylase and its relationship to oxidative stress.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gastrointestinal Agents; Gene E | 2021 |
Glycine Transporter-1 and glycine receptor mediate the antioxidant effect of glycine in diabetic rat islets and INS-1 cells.
Topics: Animals; Apoptosis; Diabetes Mellitus, Experimental; Glucose; Glycine; Glycine Plasma Membrane Trans | 2018 |
Glycine mitigates renal oxidative stress by suppressing Nox4 expression in rats with streptozotocin-induced diabetes.
Topics: Administration, Oral; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Express | 2018 |
Roxadustat promotes angiogenesis through HIF-1α/VEGF/VEGFR2 signaling and accelerates cutaneous wound healing in diabetic rats.
Topics: Angiogenesis Inducing Agents; Animals; Blotting, Western; Cells, Cultured; Diabetes Mellitus, Experi | 2019 |
Glycine increases glyoxalase-1 function by promoting nuclear factor erythroid 2-related factor 2 translocation into the nucleus of kidney cells of streptozotocin-induced diabetic rats.
Topics: Animals; Cell Nucleus; Diabetes Mellitus, Experimental; Gene Expression Regulation; Glycine; Kidney; | 2019 |
Chromium(III) Glycinate Complex Supplementation Improves the Blood Glucose Level and Attenuates the Tissular Copper to Zinc Ratio in Rats with Mild Hyperglycaemia.
Topics: Animals; Chromium; Coordination Complexes; Copper; Diabetes Mellitus, Experimental; Glycine; Hypergl | 2020 |
Protective effect of glycine in streptozotocin-induced diabetic cataract through aldose reductase inhibitory activity.
Topics: Aldehyde Reductase; Animals; Blood Glucose; Body Weight; Cataract; Diabetes Complications; Diabetes | 2019 |
Choline treatment affects the liver reticuloendothelial system and plasma fatty acid composition in diabetic rats.
Topics: Aniline Compounds; Animals; Blood Glucose; Choline; Diabetes Mellitus, Experimental; Fatty Acids; Ga | 2013 |
Role of hydrogen sulfide in the pain processing of non-diabetic and diabetic rats.
Topics: Algorithms; Alkynes; Animals; Blood Glucose; Cystathionine gamma-Lyase; Cysteine; Data Interpretatio | 2013 |
Acetyl-l-carnitine and oxfenicine on cardiac pumping mechanics in streptozotocin-induced diabetes in male Wistar rats.
Topics: Acetylcarnitine; Animals; Antioxidants; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Glycine; | 2013 |
Pharmacological effects of JTT-551, a novel protein tyrosine phosphatase 1B inhibitor, in diet-induced obesity mice.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glu | 2014 |
Dimethyloxalylglycine lyophilized onto bone substitutes increase vessel area in rat calvarial defects.
Topics: Angiogenesis Inducing Agents; Animals; Bone Regeneration; Bone Substitutes; Deferoxamine; Diabetes M | 2015 |
Alterations of urinary metabolite profile in model diabetic nephropathy.
Topics: Aconitic Acid; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitu | 2015 |
Enhanced GABA action on the substantia gelatinosa neurons of the medullary dorsal horn in the offspring of streptozotocin-injected mice.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes, Gestational; Diabetic Neuropathies; Facial Nerve | 2015 |
Reduction of spinal glycine receptor-mediated miniature inhibitory postsynaptic currents in streptozotocin-induced diabetic neuropathic pain.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glycine; Inhibitory Postsynaptic P | 2016 |
Cystathionine-γ lyase-derived hydrogen sulfide mediates the cardiovascular protective effects of moxonidine in diabetic rats.
Topics: Adiponectin; Alkynes; Animals; Baroreflex; Blood Glucose; Body Weight; Cardiotonic Agents; Cystathio | 2016 |
Effect of maternal diabetes on postnatal development of brush border enzymes and transport functions in rat intestine.
Topics: Alkaline Phosphatase; Alloxan; Animals; Birth Weight; Diabetes Mellitus, Experimental; Diabetes, Ges | 2009 |
Simultaneous determination of guanidinosuccinic acid and guanidinoacetic acid in urine using high performance liquid chromatography/tandem mass spectrometry.
Topics: Animals; Arginine; Chromatography, High Pressure Liquid; Creatinine; Diabetes Mellitus; Diabetes Mel | 2010 |
(99m)Tc sulfur colloid and (99m)Tc mebrofenin hepatobiliary functional liver imaging in normal and diabetic rats.
Topics: Aniline Compounds; Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Glycine; Imino | 2011 |
The protective role of hydrogen sulfide in myocardial ischemia-reperfusion-induced injury in diabetic rats.
Topics: Alkynes; Animals; Apoptosis; Caspase 3; Diabetes Mellitus, Experimental; Down-Regulation; Enzyme Inh | 2011 |
Glycine therapy inhibits the progression of cataract in streptozotocin-induced diabetic rats.
Topics: Administration, Oral; Aldehyde Reductase; Animals; Catalase; Cataract; Crystallins; Diabetes Mellitu | 2012 |
Effect of glycine in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Glycine; Male; Rats; Rats, Wis | 2003 |
Incorporation of C14-amino acids into glutathione and protein fractions of normal and diabetic rat tissues.
Topics: Amino Acids; Animals; Diabetes Mellitus, Experimental; Glutathione; Glycine; Liver; Proteins; Rats | 1953 |
[Peptic synthesis in alloxan diabetes].
Topics: 4-Aminobenzoic Acid; Animals; Biochemical Phenomena; Diabetes Mellitus; Diabetes Mellitus, Experimen | 1958 |
Role of the Strecker degradation of alpha-amino acid in alloxan diabetes.
Topics: Alanine; Amino Acids; Animals; Diabetes Mellitus, Experimental; Glycine | 1962 |
TRANSPORT AND INCORPORATION OF AMINO ACIDS INTO THE AORTIC WALL: INFLUENCE OF AGE AND HORMONES.
Topics: Aging; Alanine; Amino Acids; Aminobutyrates; Animals; Aorta; Carbon Isotopes; Diabetes Mellitus, Exp | 1964 |
THE UPTAKE OF AMINO ACIDS BY MOUSE PANCREAS IN VITRO. I. GENERAL CHARACTERISTICS.
Topics: Amino Acids; Animals; Biological Transport; Carbon Isotopes; Cycloparaffins; Diabetes Mellitus, Expe | 1964 |
INFLUENCE OF CORTISOL AND INSULIN ON IN VITRO INCORPORATION OF AMINO ACIDS INTO PROTEIN OF GRANULOMA TISSUE.
Topics: Adrenalectomy; Amino Acids; Animals; Carbon Isotopes; Diabetes Mellitus, Experimental; DNA; Glycine; | 1964 |
Effect of supplemental L-arginine on the function of T lymphocytes and the formation of advanced glycosylated end products in rats with streptozotocin-induced diabetes.
Topics: Animals; Arginine; Diabetes Mellitus, Experimental; Dose-Response Relationship, Immunologic; Fructos | 2005 |
Oral glycine administration attenuates diabetic complications in streptozotocin-induced diabetic rats.
Topics: Administration, Oral; Aneurysm; Animals; Cerebral Arteries; Diabetes Mellitus, Experimental; Diabeti | 2006 |
The dual peroxisome proliferator-activated receptor alpha/gamma activator muraglitazar prevents the natural progression of diabetes in db/db mice.
Topics: Animals; Body Weight; C-Peptide; Diabetes Mellitus, Experimental; Disease Progression; Fatty Acids, | 2007 |
Glycine transporter inhibitors as a potential therapeutic strategy for chronic pain with memory impairment.
Topics: Acute Disease; Analgesics; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Glycine; | 2008 |
Formation of arginine and guanidinoacetic acid in the kidney in vivo. Their relations with the liver and their regulation.
Topics: Animals; Arginine; Citrulline; Diabetes Mellitus, Experimental; Diet; Glycine; Hepatectomy; Insulin; | 1981 |
In vivo studies on basement membrane synthesis in diabetic and nondiabetic rats.
Topics: Animals; Basement Membrane; Blood Glucose; Collagen; Diabetes Mellitus, Experimental; Glycine; Hydro | 1982 |
[Guanidinoacetic acid in serum, urine and renal cortex from streptozotocin-induced diabetic rats].
Topics: Animals; Biomarkers; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glycine; Kidney Cortex | 1994 |
Insulin-like effects of bis-glycinato oxovanadium (IV) complex on experimental diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glycine; Insulin; Lipids; Liver; Male; Rats | 1993 |
Effect of diabetes on levels and uptake of putative amino acid neurotransmitters in rat retina and retinal pigment epithelium.
Topics: Analysis of Variance; Animals; Aspartic Acid; Diabetes Mellitus, Experimental; gamma-Aminobutyric Ac | 1996 |
Involvement of the central tachykinin NK1 receptor during maintenance of mechanical hypersensitivity induced by diabetes in the rat.
Topics: Animals; Benzofurans; Carbamates; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Electrophy | 1998 |
Converting enzyme inhibition and the glomerular hemodynamic response to glycine in diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Capillaries; Diabetes Mellitus, Experimental; Ena | 1999 |
Inhibition of hemoglobin glycation with glycine in induced diabetes mellitus in rats.
Topics: Animals; Blood Glucose; Depression, Chemical; Diabetes Mellitus, Experimental; Glycated Hemoglobin; | 1999 |
Inhibition of CD95 ligand-mediated inflammation.
Topics: Animals; Antineoplastic Agents; Cell Division; Diabetes Mellitus, Experimental; Fas Ligand Protein; | 2000 |
Glomerulotubular balance, dietary protein, and the renal response to glycine in diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dietary Proteins; Glomerular Filtr | 2002 |
A biodegradable injectable implant sustains systemic and ocular delivery of an aldose reductase inhibitor and ameliorates biochemical changes in a galactose-fed rat model for diabetic complications.
Topics: Absorbable Implants; Aldehyde Reductase; Animals; Diabetes Mellitus, Experimental; Disease Models, A | 2002 |
Diglycine absorption in streptozotocin diabetic rat.
Topics: Animals; Diabetes Mellitus, Experimental; Dipeptides; Glycine; Intestinal Absorption; Intestine, Sma | 1978 |
Renal functional reserve in the early stage of experimental diabetes.
Topics: Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Diabetes Mellitus, Experimental; Enal | 1992 |
Diabetes-induced bile acid composition changes in rat bile determined by high performance liquid chromatography.
Topics: Animals; Bile; Bile Acids and Salts; Cholesterol; Chromatography, High Pressure Liquid; Diabetes Mel | 1991 |
Syntheses of tolrestat analogues containing additional substituents in the ring and their evaluation as aldose reductase inhibitors. Identification of potent, orally active 2-fluoro derivatives.
Topics: Administration, Oral; Aldehyde Reductase; Animals; Cattle; Chemical Phenomena; Chemistry; Diabetes M | 1991 |
[Study of impaired metabolism of guanidinoacetic acid in uremia--the compensatory role of the pancreas in guanidinoacetic acid synthesis].
Topics: Acute Disease; Animals; Diabetes Mellitus, Experimental; Ethionine; Glycine; Insulin; Male; Pancreas | 1989 |
Gluconeogenesis from glycine and serine in fasted normal and diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Fasting; Gluconeogenesis; Glycine; Male; Ra | 1988 |
Phosphate restriction reduces proteinuria of the uninephrectomized, diabetic rat.
Topics: Aluminum Hydroxide; Animals; Blood Pressure; Cardiac Output; Diabetes Mellitus, Experimental; Glomer | 1988 |
Dynamic aspects of amino acid metabolism in alloxan-induced diabetes and insulin-treated rabbits: in vivo studies with 15N and gas chromatography-mass spectrometry.
Topics: Alanine; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Food; Gas Chromatography-Mass Spec | 1986 |
Intestinal adaptation in diabetes: amino acid absorption.
Topics: Amino Acids; Aminoisobutyric Acids; Animals; Biological Transport; Chromatography, Paper; Diabetes M | 1974 |
[Effect of alloxan diabetes, insulin and diabetogenic hormones (thyroxine, hydrocortisone and oxytocin) on the intestinal transport of glycine].
Topics: Animals; Biological Transport; Blood Glucose; Diabetes Mellitus, Experimental; Glycine; Hydrocortiso | 1971 |
Effect of insulin on the injury-stimulated synthesis of serum albumin in the rat.
Topics: Animals; Blood Glucose; Blood Proteins; Carbon Isotopes; Dactinomycin; Diabetes Mellitus, Experiment | 1970 |
Studies on cholesterol metabolism in experimental diabetic rat.
Topics: Animals; Bile Acids and Salts; Carbon Isotopes; Cholesterol; Diabetes Mellitus, Experimental; Dietar | 1970 |
Potential alloxan-diabetic compounds from the reaction of alloxan, glutathione and nitrogen bases.
Topics: Absorption; Acetates; Alloxan; Amino Acids; Animals; Buffers; Butyrates; Chemical Phenomena; Chemist | 1970 |
[Effect of sulfur-containing compounds on experimental diabetes. I. Relationship between hypoglycemic action and the concentration of acid soluble SH and S-S groups in blood].
Topics: Animals; Blood Glucose; Cystine; Diabetes Mellitus, Experimental; Glutathione; Glycine; Insulin; Mal | 1968 |
[Effect of sulfur-containing compounds on experimental diabetes. II. Correlation between blood sugar level and variation in acid-soluble SH and S-S group in blood during insulin secretion or insulin action].
Topics: Animals; Blood Glucose; Cystine; Diabetes Mellitus, Experimental; Epinephrine; Glucagon; Glucose; Gl | 1969 |
[Effect of sulfur-containing compounds on experimental diabetes. IV. Variation in the plasma insulin level by the administration of glutathione, 2-mercaptopropionylglycine, cysteine and their oxidized type compounds].
Topics: Animals; Cysteine; Diabetes Mellitus, Experimental; Glutathione; Glycine; Insulin; Male; Rabbits; Ra | 1969 |
[Effect of sulfur-containing compounds on experimental diabetes. V. Effect of thiol and its oxidized type compounds on the liveration of pancreatic insulin].
Topics: Animals; Diabetes Mellitus, Experimental; Glucose; Glutathione; Glycine; In Vitro Techniques; Insuli | 1969 |